Pancreatic cancer diagnosis on unenhanced CT with deep learning for opportunistic diagnosis
Open Access
- 3 March 2026
- journal article
- Published by Oxford University Press (OUP) in Radiology Advances
- Vol. 3 (2)
Abstract
Background: Pancreatic cancer (PC) is frequently missed on unenhanced CT examinations performed for unrelated clinical indications, where the pancreas is included incidentally and clinical suspicion is low. Purpose: To develop and validate a deep learning-based tool for PC diagnosis and risk stratification on unenhanced CT. Materials and Methods: This retrospective study included 3080 unenhanced CT studies of Taiwanese patients with PC, other pancreatic diseases and normal pancreas between 2004 and 2019 from a tertiary hospital, randomly divided into training, validation, and internal test sets. Unenhanced CT studies from United States institutions were used for external testing. A hybrid convolutional neural network–transformer model was trained for PC diagnosis and risk stratification. Performance was evaluated using sensitivity, specificity, and area under the curve (AUC), with comparisons to 2 radiologists by McNemar’s test and exploratory decision curve analysis. Results: The internal dataset included 713 PCs (mean age, 64.6 ± 12.0 years; 384 men), 1661 normal pancreas and 706 other pancreatic diseases. In an exploratory comparison restricted to unenhanced CT (29 PCs, 31 controls), the sensitivity of computer-aided diagnosis (CAD) tool (89.7%, 72.6-97.8) seemed comparable with that of 1 radiologist (86.2%, 68.3-96.1) and higher than another (41.4%, 23.5-61.1); but wide confidence intervals and inter-radiologist variability warrant cautious interpretation. In the internal test set (142 PCs, 474 controls), sensitivity was 90.8% (84.9-95.0) and specificity 93.0% (90.4-95.2) (AUC: 0.98), with sensitivity comparable to radiologist reports based on enhanced and unenhanced CT (95.4%, 90.2-98.3; P = .21). In the external set (42 PCs, 22 controls), sensitivity was 76.2% (60.5-87.9) and specificity 86.4% (65.1-97.1) (AUC: 0.89). The tool stratified cases into 7 risk levels with likelihood ratios ranging from <0.01 to 173.46. Exploratory decision curve analysis suggested potential net benefit across threshold probabilities. Conclusion: This tool may assist in the opportunistic detection and risk stratification of PC on unenhanced CT.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (NSTC-113-2123-M-002-017-)
- Ministry of Science and Technology, Taiwan (NSTC-114-2123-M-002-010-)
This publication has 18 references indexed in Scilit:
- Radiomics-based Machine-learning Models Can Detect Pancreatic Cancer on Prediagnostic Computed Tomography Scans at a Substantial Lead Time Before Clinical DiagnosisGastroenterology, 2022
- Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal AdenocarcinomaCurrent Medical Science, 2022
- Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous PancreasRadiology: Imaging Cancer, 2021
- Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinomaEuropean Radiology, 2020
- Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validationThe Lancet Digital Health, 2020
- Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinomaAbdominal Radiology, 2020
- Diagnosis and Detection of Pancreatic CancerThe Cancer Journal, 2017
- Rationale use of unenhanced multi-detector CT (CT KUB) in evaluation of suspected renal colicInternational Journal of Surgery, 2012
- Imaging of pancreatic cancer: An overview2011
- Diagnostic tests 4: likelihood ratiosBMJ, 2004